Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck
Clinical trial NCT03854032 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03854032
- Sponsor
- Thomas Jefferson University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-09
- Primary completion
- 2025-12-31
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.